SCHEMBL27767702

SCHEMBL27767702

CC(C)(C)OC(=O)NCc1cc([N+](=O)[O-])ccc1OC(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.44
ITGA4 P13612 1/20 0.43
ITGB7 P26010 1/20 0.43
MAPT P10636 4/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GNRHR P30968 1/20 0.42
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
BRD4 O60885 1/20 0.41
HTT P42858 2/20 0.40
PKM P14618 1/20 0.40
POLB P06746 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP8 P22894 1/20 0.39
MMP13 P45452 1/20 0.39
MEN1 O00255 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6681877 0.87 GNRHR (0.49) ALOX5MAPTSMN1; SMN2GNRHRHTT
SCHEMBL6676086 0.85 NPBWR1 (0.54) ALOX5ITGA4ITGB7MAPTRAB9A
SCHEMBL12227518 0.84 CYP19A1 (0.46) ALOX5ITGA4ITGB7MAPTRAB9A
SCHEMBL12330621 0.82 ALOX5 (0.48) ALOX5ITGA4ITGB7MAPTRAB9A
SCHEMBL16307013 0.82 ALOX5 (0.49) ALOX5ITGA4ITGB7MAPTRAB9A
SCHEMBL31455922 0.81 MAPT (0.45) ALOX5ITGA4ITGB7MAPTRAB9A
SCHEMBL399470 0.81 ALOX5 (0.47) ALOX5ITGA4ITGB7MAPTRAB9A
SCHEMBL2858710 0.81 ALOX5 (0.47) ALOX5ITGA4ITGB7MAPTRAB9A
SCHEMBL5413213 0.81 MEN1 (0.52) ALOX5ITGA4ITGB7MAPTRAB9A
SCHEMBL31758898 0.81 DDR1 (0.45) MAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101611019-A The big ring serum prothrombin conversion accelerator (SPCA) a inhibitor that can be used as anticoagulant BRISTOL MYERS SQUIBB CO (US) 2009-12-23 CN disclosed